Home / Brands / Johnson Matthey
Johnson Matthey Recalls
5 recalls on record · April 10, 2019 to October 2, 2019 · Drugs
October 2, 2019DrugsFDA
Johnson Matthey Inc. recalls Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford,
Hazard: cGMP Deviations: Potential glass contamination
October 2, 2019DrugsFDA
Johnson Matthey Inc. recalls Cisplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ
Hazard: cGMP Deviations: Potential glass contamination
October 2, 2019DrugsFDA
Johnson Matthey Inc. recalls Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptf
Hazard: cGMP Deviations: Potential glass contamination
April 24, 2019DrugsFDA
Johnson Matthey Inc. recalls Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass con
Hazard: Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.
April 10, 2019DrugsFDA
Johnson Matthey Inc. recalls Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 N
Hazard: Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.